HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPARgamma.

Abstract
Deoxyelephantopin (ESD) was reported to potentiate apoptosis, inhibit invasion and abolish osteoclastogenesis but no target protein was disclosed. Here, we discovered that ESD could significantly inhibit the proliferation of different cancer cells and induce apoptosis and cell cycle arrest at G(2)/M phase in HeLa cell. Moreover, biochemical and biophysical assays revealed that ESD acted as a specific partial agonist against PPARgamma. Molecular docking with site-directed mutagenesis analyses indicated that ESD functioned as a partial agonist of PPARgamma by adopting a distinct binding mode to PPARgamma compared with rosiglitazone. The PPARgamma knockdown results indicated that the inhibition of ESD against the cancer cell proliferation is more possibly through PPARgamma-independent pathway and our findings might supply potent binding features for ESD/PPARgamma interaction at atomic level, and shed light on the potential acting target information for this natural compound.
AuthorsGang Zou, Zhenting Gao, Jidong Wang, Yu Zhang, Hong Ding, Jin Huang, Lili Chen, Yuewei Guo, Hualiang Jiang, Xu Shen
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 75 Issue 6 Pg. 1381-92 (Mar 15 2008) ISSN: 1873-2968 [Electronic] England
PMID18164690 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Lactones
  • PPAR gamma
  • Sesquiterpenes
  • deoxyelephantopin
Topics
  • Animals
  • Antineoplastic Agents (metabolism, pharmacology)
  • Apoptosis
  • COS Cells
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Chlorocebus aethiops
  • HeLa Cells
  • Humans
  • Lactones (metabolism, pharmacology)
  • Models, Molecular
  • PPAR gamma (agonists, metabolism)
  • Sesquiterpenes (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: